Literature DB >> 11540685

Biomedical aspects of artificial gravity.

I F Vil-Viliams1, A R Kotovskaya, A A Shipov.   

Abstract

Artificial gravity (AG) is the basic challenge for space biology and medicine. The importance of this problem is associated with the fact that duration of the space missions will become progressively longer, but the presently available countermeasures do not provide reason enough to predict the human health safety during space missions of any duration. The creation of AG could be an efficient method for removing the negative effects of microgravity. Two principle methods of generating AG, rotation of space system (SS) and building of short arm centrifuge (SAC), have been proposed. The purpose of the present work is to review the biomedical aspects of AG in the context of its use in long-term space missions.

Entities:  

Mesh:

Year:  1997        PMID: 11540685

Source DB:  PubMed          Journal:  J Gravit Physiol        ISSN: 1077-9248


  5 in total

Review 1.  Cardiovascular deconditioning in microgravity: some possible countermeasures.

Authors:  G Antonutto; P E di Prampero
Journal:  Eur J Appl Physiol       Date:  2003-07-08       Impact factor: 3.078

Review 2.  Centrifugation as a countermeasure during actual and simulated microgravity: a review.

Authors:  G Clément; A Pavy-Le Traon
Journal:  Eur J Appl Physiol       Date:  2004-05-20       Impact factor: 3.078

3.  The therapeutic benefits of gravity in space and on earth.

Authors:  C Kourtidou-Papadeli; C L Papadelis; J Vernikos; P D Bamidis; M Hitoglou-Antoniadou; E Perantoni; E Vlachogiannis
Journal:  Hippokratia       Date:  2008-08       Impact factor: 0.471

Review 4.  The energetics of cycling on Earth, Moon and Mars.

Authors:  Stefano Lazzer; Luca Plaino; Guglielmo Antonutto
Journal:  Eur J Appl Physiol       Date:  2010-03-27       Impact factor: 3.078

Review 5.  Region-specific vascular remodeling and its prevention by artificial gravity in weightless environment.

Authors:  Li-Fan Zhang
Journal:  Eur J Appl Physiol       Date:  2013-03-24       Impact factor: 3.078

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.